Brian Wainger

Credentials: · · · · ·

History

Developing Non-Viral Gene Therapy for Acute Pain Treatment
National Institute of Neurological Disorders and Stroke · R61
Contact PI · $1.1M · Massachusetts General Hospital
2026–2028
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $682.8K · Massachusetts General Hospital
2023–2027
From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects
National Institute of Neurological Disorders and Stroke · RM1
Contact PI · $11.9M · Massachusetts General Hospital
2022–2027
Electrophysiological and Ultrasound Quantitative Biomarkers for Myofascial Pain
National Center for Complementary and Integrative Health · R33
PI · $2.3M · Beth Israel Deaconess Medical Center
2022–2027

From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects
Principal investigator · Recruiting · Phase 2
Massachusetts General Hospital
2023–2027
Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
Principal investigator · Completed · Phase 2
Brian Wainger
2015–2018
Study of Sulfasalazine in Treating Painful Neuropathy
Principal investigator · Terminated · Phase 2
Massachusetts General Hospital
2013–2017
Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.
Principal investigator · Terminated
Massachusetts General Hospital
2011–2014